Beijing GoBroad Hospital Co., Ltd.

Beijing GoBroad Hospital provides comprehensive, integrated medical services supported by outpatient consultations, inpatient care, diagnostic services, emergency response, and surgical procedures. 

The hospital functions as a contemporary general facility handle a variety of clinical issues by way of integrated divisions, specialized medical facilities, and structured lodging units, enabling it to address varying tiers of healthcare requirements.

Beijing GoBroad Hospital combines outpatient services, inpatient care, diagnostic evaluations, and surgical procedures in one facility. Its clinical model accommodates both routine treatments and complex care, supported by multidisciplinary teams, advanced diagnostic tools, operating rooms, and a well-organized inpatient ward.

• 500+ bed capacity: The hospital has a planned total of around 500 beds, including units dedicated to clinical research and early‑phase care.
• Cutting‑edge oncology focus: As part of GoBroad Healthcare Group, the hospital specialises in haematology, oncology, and advanced cellular therapies like CAR‑T immunotherapy.
• High CAR‑T treatment volume: The facility is recognised for handling thousands of CAR‑T cell therapy cases, making it one of the leading private centres for this advanced treatment.
• Global Reach: Patients from 80+ countries have been served by GoBroad Oncology and haematology programs.
• Research and innovation ecosystem: Operates within a broader healthcare group with nearly 1,500 beds across 8 hospitals in Beijing, Shanghai, and Guangzhou, emphasising clinical research integration.

The hospital prioritises patient safety, clinical governance, and the maintenance of established health standards and hospital protocols in China. Through coordinated services and a streamlined hospital environment, Beijing GoBroad Hospital continues to deliver structured, quality medical care to both domestic and international patients, including Bangladeshi patients seeking quality treatment in Beijing.